Exact Mass: 680.2410056
Exact Mass Matches: 680.2410056
Found 56 metabolites which its exact mass value is equals to given mass value 680.2410056
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Foscan
C44H32N4O4 (680.2423431999999)
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01X - Other antineoplastic agents > L01XD - Sensitizers used in photodynamic/radiation therapy D011838 - Radiation-Sensitizing Agents > D017319 - Photosensitizing Agents D000970 - Antineoplastic Agents C1420 - Photosensitizing Agent D003879 - Dermatologic Agents Same as: D06066
6'-O-alpha-D-Galactopyranosylciceritol
6-O-alpha-D-Galactopyranosylciceritol is found in pulses. 6-O-alpha-D-Galactopyranosylciceritol is isolated from chickpea Isolated from chickpeas. 6-O-alpha-D-Galactopyranosylciceritol is found in pulses.
(+/-)-2-hydroxy-5-benzylisouvarinol-B|(+/-)-2-hydroxy-5-benzylisouvarinol-B5|2 -hydroxy-5-benzylisouvarinol-B|5-Benzyl-2-hydroxyisouvarinol B
2-(4-hydroxy-3-methoxyphenyl)ethyl 2-O-acetyl-4-O-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]-3-O-alpha-L-rhamnopyranosyl-beta-D-glucopyranoside|salsaside E
sinapyl alcohol 9-O-caffeoyl-4-O-alpha-rhamnopyranosyl-(1->2)-beta-glucopyranoside|solargin II
2 -hydroxy-3 -benzyluvarinol|3-Benzyl-2-hydroxyuvarinol
2 -hydroxy-5 -benzylisouvarinol-A|5-Benzyl-2-hydroxyisouvarinol A
pycnamine
C37H42Cl2N2O6 (680.2419772000001)
Berbamine dihydrochloride is an inhibitor of NF-κB activity with remarkable anti-myeloma efficacy. Berbamine dihydrochloride is an inhibitor of NF-κB activity with remarkable anti-myeloma efficacy.
C32H40O16_beta-D-Glucopyranoside, (1aS,1bS,2S,5aR,6S,6aS)-6-[[3-O-acetyl-6-deoxy-2-O-[(2E)-1-oxo-3-phenyl-2-propen-1-yl]-alpha-L-mannopyranosyl]oxy]-1a,1b,2,5a,6,6a-hexahydro-1a-(hydroxymethyl)oxireno[4,5]cyclopenta[1,2-c]pyran-2-yl
C32H40O16_(1aS,1bS,2S,5aR,6S,6aS)-6-({3-O-Acetyl-6-deoxy-4-O-[(2E)-3-phenyl-2-propenoyl]-alpha-L-mannopyranosyl}oxy)-1a-(hydroxymethyl)-1a,1b,2,5a,6,6a-hexahydrooxireno[4,5]cyclopenta[1,2-c]pyran-2-yl beta-L-glucopyranoside
Hydroxypropyl Methyl Cellulose
6''-O-a-D-Galactopyranosylciceritol
d-tubocurarine chloride
C37H42Cl2N2O6 (680.2419772000001)
D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents > D009466 - Neuromuscular Blocking Agents D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists C78281 - Agent Affecting Musculoskeletal System > C29696 - Muscle Relaxant
TEMOPORFIN
C44H32N4O4 (680.2423431999999)
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01X - Other antineoplastic agents > L01XD - Sensitizers used in photodynamic/radiation therapy D011838 - Radiation-Sensitizing Agents > D017319 - Photosensitizing Agents D000970 - Antineoplastic Agents C1420 - Photosensitizing Agent D003879 - Dermatologic Agents
6-C-methyl-alpha-D-mannosyl-(1->2)-alpha-D-mannosyl-(1->2)-alpha-D-mannosyl-(1->3)-alpha-D-mannose
6-[8-(2,4-dihydroxyphenyl)-7-[(2E)-3,7-dimethylocta-2,6-dienyl]-2-(hydroxymethyl)-2-methyl-6-oxopyrano[3,2-g]chromen-5-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
Foscan
C44H32N4O4 (680.2423431999999)
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01X - Other antineoplastic agents > L01XD - Sensitizers used in photodynamic/radiation therapy D011838 - Radiation-Sensitizing Agents > D017319 - Photosensitizing Agents D000970 - Antineoplastic Agents C1420 - Photosensitizing Agent D003879 - Dermatologic Agents Same as: D06066
3-[2-(2-{[3-(2-{2-[(3,4-dihydroxybutanoyl)oxy]propyl}-4,6-dihydroxybenzoyloxy)butanoyl]oxy}propyl)-4,6-dihydroxybenzoyloxy]butanoic acid
(1's,2r,2's,3's,4'r,7's,8'z,10'z,12's,13's,14'r,15'r,16'r)-2',12',14',15',16'-pentakis(acetyloxy)-3'-hydroxy-4',13'-dimethyl-5'-oxo-6'-oxaspiro[oxirane-2,17'-tricyclo[11.4.0.0³,⁷]heptadecane]-8',10'-dien-9'-ylmethyl acetate
1-(2-{2-[(3-amino-8,8-dichloro-1,2-dihydroxyoctylidene)amino]-3-(4-hydroxyphenyl)-n-methylpropanamido}-3-(4-hydroxyphenyl)propanoyl)pyrrolidine-2-carboxylic acid
C32H42Cl2N4O8 (680.2379552000001)
4-methoxy-6-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}cyclohexane-1,2,3,5-tetrol
(2e)-3-(4-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-3,5-dimethoxyphenyl)prop-2-en-1-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
5-(acetyloxy)-6-[2-(4-hydroxy-3-methoxyphenyl)ethoxy]-2-(hydroxymethyl)-4-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-3-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate
(2s,3r,4r,5s,6s)-4-(acetyloxy)-5-hydroxy-2-{[(1s,2s,4s,5s,6r,10s)-2-(hydroxymethyl)-10-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,9-dioxatricyclo[4.4.0.0²,⁴]dec-7-en-5-yl]oxy}-6-methyloxan-3-yl (2e)-3-phenylprop-2-enoate
[(2r,3r,4s,5r,6r)-5-(acetyloxy)-6-[2-(3,4-dihydroxyphenyl)ethoxy]-3-hydroxy-4-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]methoxy}oxan-2-yl]methyl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
(2s,3r,4r,5s,6s)-4-(acetyloxy)-5-hydroxy-2-{[(1r,2s,4s,5s,6s,10s)-2-(hydroxymethyl)-10-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,9-dioxatricyclo[4.4.0.0²,⁴]dec-7-en-5-yl]oxy}-6-methyloxan-3-yl (2e)-3-phenylprop-2-enoate
4-(acetyloxy)-5-hydroxy-2-{[2-(hydroxymethyl)-10-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,9-dioxatricyclo[4.4.0.0²,⁴]dec-7-en-5-yl]oxy}-6-methyloxan-3-yl 3-phenylprop-2-enoate
(2s)-1-[(2s)-2-[(2s)-2-[(3-amino-8,8-dichloro-1,2-dihydroxyoctylidene)amino]-3-(4-hydroxyphenyl)-n-methylpropanamido]-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carboxylic acid
C32H42Cl2N4O8 (680.2379552000001)